Related Experiment Video
Updated: Jul 1, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Urokinase-type plasminogen activator receptor: a beacon of malignancy?
Ronny Drapkin1, Adam Clauss, Steven Skates
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. ronny_drapkin@dfci.harvard.edu
Abstract:
Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Identification of serum biomakers that can rellably make the distinction would aid in the proper referral for patient care and may provide leads in the development of early detection strategies.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...